Evaluating the Wilms' tumour antigen (WT1) as a target for the immunotherapy of malignancies
The Wilms' tumour antigen 1 (WT1) is a transcription factor which is over-expressed in several leukaemias and solid tumours. Currently, there is limited information about the expression and immunogenicity of WT1 in prostate cancer. I used immunohistochemistry to analyse WT1 expression in prosta...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.505296 |